Q EARNINGS CALL FEBRUARY 20, 2018

Transcription

1 Q EARNINGS CALL FEBRUARY 20,

2 IMPORTANT INFORMATION Forward Looking Statements These slides contain (and the accompanying oral discussion will contain) forward looking statements. All statements other than statements of historical fact or relating to present facts or current conditions are forward looking statements. Such statements involve known and unknown risks, uncertainties and other factors that could cause the actual results of the Company to differ materially from the results expressed or implied by such statements, including general economic and business conditions, conditions affecting the industries served by the Company and its subsidiaries, conditions affecting the Company s customers and suppliers, competitor responses to the Company s products and services, the overall market acceptance of such products and services, increases in the Company s cost structure, the rate of economic development and growth in emerging markets, the Company s exposure to fluctuations in currencies, the Company s ability to successfully implement its strategic initiatives to increase cost savings and improve operating margins, the integration of acquisitions and other factors disclosed in the Company s periodic reports. Such risks and other factors that may impact management s beliefs and assumptions are more particularly described in the Company s Form 10 K filed with the Securities and Exchange Commission (the SEC ) on February 28, 2017 under the caption Risk Factors. Consequently such forward looking statements should be regarded as the Company s current plans, estimates and beliefs. The forward looking statements in these slides are made only as of the date hereof. The Company does not undertake and specifically declines any obligation to publicly release the results of any revisions to these forward looking statements that may be made to reflect any future events or circumstances after the date of such statements or to reflect the occurrence of anticipated or unanticipated events, except to the extent required by law. All of the Company s forward looking statements should be considered in light of these factors. Non GAAP Financial Measures These slides contain financial measures which have not been calculated in accordance with generally accepted accounting principles in the United States ( U.S. GAAP ), including Adjusted EBITDA, Adjusted Net Income and Free Cash Flow. These non GAAP financial measures should be considered only as supplemental to, and not as an alternative to, financial measures prepared in accordance with U.S. GAAP. Please refer to the appendix of this presentation for a reconciliation of Adjusted EBITDA, Adjusted Net Income and Free Cash Flow to the most directly comparable U.S. GAAP financial measures. We believe that the inclusion of Adjusted EBITDA is useful to provide additional information to investors about certain material non cash items, as well as items considered to be one time or non recurring to the operations of the business. We believe the presentation of Adjusted Net Income enhances our investors overall understanding of the financial performance and cash flow of our business. We believe the presentation of Free Cash Flow is useful to investors because it measures the operating cash flow of the Company, excluding the capital that is spent to continue and improve business operations, such as investment in the Company's existing business. Our use of the terms Adjusted EBITDA, Adjusted Net Income and Free Cash Flow may vary from that of others in our industry. This presentation should be read in conjunction with Management s Discussion and Analysis of Financial Condition and Results of Operations and the Consolidated Financial Statements presented within our Form 10 K filed with the SEC on February 28,

3 Q FINANCIAL RESULTS Sales of $324.9 million increased +12% vs prior year; +9% on a constant currency basis Operating earnings (GAAP) increased 15% to $10.1 million; Adjusted EBITDA (non GAAP) increased +13% to $60.4 million Diluted EPS (GAAP) increased to $0.05, up from $0.02 Q4 16; Diluted adjusted EPS (non GAAP) increased +26% to $0.59 Free Cash Flow of $95.5 million, versus $29.2 million prior year Orders up +9% versus the prior year; +5% (constant currency) Total Backlog of $287.0 million, versus $225.6 million prior year Q4 Financial Highlights Sales (1) EBITDA Net Income (2,3) EPS (2,3) Free Cash Flow $ % $324.9 $ % $ % 18.6% $60.4 $ % $ % $0.47 $0.59 +$66 $1.5 $29.2 $95.5 Q4 16 Q4 17 Q4 16 Q4 17 Q4 16 Q4 17 Q4 16 Q4 17 Q4 16 Q (1) Q sales of $315.1 million are on a constant currency basis. (2) Q4 16 Adj Net Income and Adj EPS values include $8.5M income tax benefit due to change in the ownership structure of our German subsidiaries. (3) Q4 17 Adj Net Income and Adj EPS values include $8.9M income tax benefit as a result of U.S. Tax Reform

4 FY 2017 FINANCIAL RESULTS Sales of $1.2 billion increased +6% vs prior year; +5% on a constant currency basis Operating earnings (GAAP) declined 17% to $88.0 million; Adjusted EBITDA (non GAAP) increased +7% to $227.3 million Diluted EPS (GAAP) of $0.02; Diluted adjusted EPS (non GAAP) of $1.81 Free Cash Flow of $83.2 million, versus $59.8 million prior year Orders up +9% versus the prior year; +8% (constant currency) Net Debt Leverage from 3.9x to 3.3x Cash from $130 million to $188 million ($93 million end of Q3 17) 2017 Financial Highlights Sales (1) EBITDA Net Income (2,3) EPS (2,3) Free Cash Flow +5% $1,234 $1, % +7% 18.4% $ % $ % $1.81 $1.5 +$23 $83.2 $1,167 $212.8 $105.7 $1.51 $59.8 YTD 16 YTD 17 YTD 16 YTD 17 YTD 16 YTD 17 YTD 16 YTD 17 YTD 16 YTD 17 4 (1) YTD 2017 sales of $1,227 million are on a constant currency basis. (2) Q4 16 Adj Net Income and Adj EPS values include $8.5M income tax benefit due to change in the ownership structure of our German subsidiaries. (3) Q4 17 Adj Net Income and Adj EPS values include $8.9M income tax benefit as a result of U.S. Tax Reform

5 ORDERS Q4 '17 Results YTD Results Orders $316.3 $ % +5% Orders $1,299.9 $1, % +8% $291.1 $1,191.3 Commentary: Double digit order growth in China and India, partially offset by modest declines in North America and Europe Order momentum in the Consumables portfolio continued into Q4 Commentary: Growth across all major regions with particular strength in China and India Robust YTD growth across most end markets, partially offset by decreases in medical and automotive 5

6 CONSOLIDATED RESULTS Q4 '17 Results YTD Results Sales ($M) $289.1 $324.9 $ % +9% Sales ($M) $1,166.7 $1,234.2 $1, % +5% EBITDA $53.6 $ % EBITDA $212.8 $ % 6 EBITDA% 18.5% 18.6% +10 bps Q4 Sales mix: Commentary Organic Acquisition Fx As reported +9% +3% +12% Note: Sales growth rate commentary is on a constant currency basis. Q4 sales growth in all major regions driven by double digit growth in China, India and North America versus the prior year Q4 margin improvement driven by volume increases and discretionary cost controls partially offset with price, material inflation and unfavorable mix Year to date sales growth driven by emerging markets; modest growth in North America and Europe EBITDA% 18.2% 18.4% +20 bps YTD Sales mix: Organic Acquisition Fx As reported +5% +1% +6%

7 MELT DELIVERY & CONTROL SYSTEMS Q4 '17 Results YTD Results Sales ($M) $101.0 $103.6 $ % (1%) Sales ($M) $389.9 $424.0 $ % +9% EBITDA $32.6 $32.2 (1%) $127.2 EBITDA $ % EBITDA% 32.3% 31.1% (120) bps EBITDA% 32.6% 32.6% flat Commentary Q4 sales driven primarily by growth in China offset by declines in all other regions Q4 margin compression due to non recurring subcontracting costs in North America and China, as well as incremental pre hiring in anticipation of Chinese New Year 7 Solid 2017 growth driven by hot runner business; segment unfavorably impacted by material inflation

8 FLUID TECHNOLOGIES Q4 '17 Results YTD Results Sales ($M) $28.0 $31.0 $ % +5% Sales ($M) $121.2 $112.9 $ % +7% EBITDA $5.9 $ % EBITDA $24.4 $ % EBITDA% 21.1% 23.9% 280 bps EBITDA% 21.6% 22.2% 60 bps Commentary Solid Q4 and full year sales growth across all major regions driven by Europe and Asia Margin expansion driven by price and discretionary cost controls; partially offset by increased raw material costs. 8 Automotive, Industrial machinery and Consumer Goods all posted solid Q4 and full year growth versus the prior year

9 ADVANCED PLASTICS PROCESSING TECHNOLOGIES Q2' Q4 '17 Results YTD Results Sales ($M) $160.1 $190.3 $ % +16% Sales ($M) $663.9 $689.1 $ % +3% EBITDA $20.2 $ % EBITDA $81.6 $ % EBITDA% 12.6% 13.6% 100 bps EBITDA% 12.3% 12.5% 20 bps Commentary Q4 sales driven by double digit growth in India and modest growth in all other regions Q4 double digit Aftermarket growth; Full year growth of 5% Unfavorable price and material cost inflation remained a headwind throughout the year; offset by cost management and mix of India equipment business 9

10 FREE CASH FLOW Dollars in millions Q4 16 Q4 17 Adjusted EBITDA $53.6 $60.4 Less (Non discretionary items): Maintenance/Growth Capex (net) (20.1) (4.4) YTD 16 YTD 17 $212.8 $227.3 (43.6) (28.2) +/ Net Working Capital All Other 4.0 (7.6) (6.5) 0.0 Interest (5.2) (9.8) (57.0) (54.8) Cash Taxes (3.2) (4.8) (24.6) (26.2) FCF Before Restructuring (1) (2) $52.6 $112.8 $107.7 $146.5 % of EBITDA 98% 187% 51% 65% Less (Discretionary Restructuring Expenditures): Capex (net of disposals) (6.1) (1.0) One time costs (17.3) (16.3) (12.8) (7.8) (35.1) (55.5) 10 Free Cash Flow (1) $29.2 Credit Metrics: Net Debt / EBITDA Interest Coverage (1) YTD Excludes cash from financing activities including $28.7 million of refinancing costs in Q1 17 and Q4 17 (2) YTD Includes proceeds of $10.9M from the sale leaseback transaction of our Canadian properties $ x 3.3x 3.7x 4.1x $59.8 $83.2

11 IMPACT OF U.S. TAX REFORM Tax Provision Impact 2017 $8.9 million provisional tax benefit driven by: AMT credit valuation allowance release Revaluation of net deferred tax liabilities Withholding tax on planned cash repatriation from non U.S. subsidiaries Tax Provision Impact Future U.S. NOLs expected to be utilized more quickly Limitation of interest deduction Foreign earnings will be taxable in the U.S. immediately Transition tax of ~ $7 million NOLs utilized Cash Tax Impact 2017 No cash impact Cash Tax Impact Future AMT credit refund of ~ $7 million to be received over four years beginning in

12 2018 GUIDANCE 12 Annual Guidance Sales Growth Fx tailwind Adjusted EBITDA Free Cash Flow Restructuring Costs (included in FCF) Net Debt Leverage Supplemental Guidance Information: Capex Interest Expense (P&L) Cash Interest (Cash Flow) Non GAAP Tax Provision (P&L) Cash Taxes (Cash Flow) Diluted Shares Outstanding % to 4.0% ~1.0% $237M $243M (vs $227M in 2017) $80M $90M ~$55M Under 3.0x EBITDA % of Sales 20% in Q4 18 ~$45M ~$45M ~$45M ~$34M ~$34M ~72.5 million shares

13 WRAP UP Solid Quarter and Year Exceeds Expectations Sustained order growth across the business Backlog growth in Core businesses Strong Consumables growth Continued momentum in emerging markets (India, China) Significant Free Cash Flow generation 13 Innovation Maintaining a Vitality Index of 18%

14 APPENDIX 14

15 ADJ. EBITDA & ADJ. NET INCOME RECONCILIATIONS 15

16 ADJ. EBITDA & ADJ. NET INCOME RECONCILIATIONS (a) Non cash currency effect on intercompany advances primarily relatesto advances denominated in foreign currencies. The most significant exposure relates to the Canadian dollar pursuant to intercompany advances within the MDCS segment. (b) Organizational redesign costs for the three months ended December 31, 2017 primarily include $2.1 million for termination costs as a result of eliminated positions and $6.8 million of costs related to relocating our facilities in Belgium, Italy and Germany to the Czech Republic. Organizational redesign costs for the year ended December 31, 2017 primarily included $17.6 million for termination costs as a result of eliminated positions and $21.7 million of costs related to relocating our facilities in Belgium, Italy and Germany to the Czech Republic. Organizational redesign costs for the three months and year ended December 31, 2017 also included $1.7 million and $4.0 million, respectively, of costs related to our facility consolidation in North America. Organizational redesign costs for the three months ended December 31, 2016 primarily include $8.6 million for termination costs as a result of eliminated positions, $4.7 million of costs related to relocating our facilities in Belgium, Italy and Germany to the Czech Republic and $0.2 million of costs related to the restructuring of Fluids in Europe. Organizational redesign costs for the year ended December 31, 2016 primarily include $13.3 million for termination costs as a result of eliminated positions, $4.4 million of costs related to the shutdown of facilities, $5.2 million of costs related to relocating our facilities in Belgium, Italy and Germany to the Czech Republic and $0.5 million of costs related to the restructuring of Fluids in Europe. (c) Long term equity awards include the non cash charges associated with stock based compensation awards granted to certain executives and independent directors in the three months and year ended December 31, 2017 and (d) Debt costs incurred during the year ended December 31, 2017 included $25.2 million of debt extinguishment costs and $1.9 million of fees related to the new senior secured term loan facility due September 2023 ("2017 Term Loan Facility"). (e) Professional fees in the three months ended December 31, 2017 and 2016 included $1.6 million and $2.2 million of costs for strategic organizational initiatives, respectively. Professional fees in the year ended December 31, 2017 and 2016 included $6.5 million and $4.7 million of costs for strategic organizational initiatives, respectively. (f) Non cash fair market value adjustments relate to acquisition accounting for the fair market value of inventory as part of our acquisition of CanGen in the fourth quarter of (g) The annual effective tax rate adjustment primarily includes the tax benefit associated with reconciling net earnings (loss) to Adjusted Net Income. (h) Other costs for the three months and year ended December 31, 2017 primarily include $7.7 million of costs to write down the inventory of a discontinued product line and $1.4 million of goodwill impairment. Other costs for the year ended December 31, 2016 includes $1.4 million related to the impairment of certain software licenses andthewrite off of a $$0.5 million non trade receivable. 16

17 OPERATING EARNINGS TO ADJ. EBITDA RECONCILIATION in millions 17

18 OPERATING EARNINGS TO ADJ. EBITDA RECONCILIATION (a) Non cash currency effect on intercompany advances primarily relates to advances denominated in foreign currencies. The most significant exposure relates to the Canadian dollar pursuant to intercompany advances within the MDCS segment. (b) Organizational redesign costs in the three months ended December 31, 2017 included $1.9 million for termination costs as a result of eliminated positions and $6.5 million of costs related to relocating our facilities in Italy and Germany to the Czech Republic in APPT. Organizational redesign costs in the three months ended December 31, 2017 also included $0.1 million of termination costs as a result of eliminated positions and $1.7 million of costs related to our facility consolidation in North America within MDCS. Organizational redesign costs in the year ended December 31, 2017 included $13.0 million for termination costs as a result of eliminated positions and $20.8 million of costs related to relocating our facilities in Italy and Germany to the Czech Republic in APPT. Organizational redesign costs in the year ended December 31, 2017 also included $1.8 million of termination costs as a result of eliminated positions and $4.0 million of costs related to our facility consolidation in North America within MDCS. Organizational redesign costs in the three months ended December 31, 2016 included $4.6 million of costs relatedtorelocatingourfacilitiesinbelgium, Italy and Germany to the Czech Republic in APPT and MDCS and $0.2 million of costs related to the restructuring of Fluids in Europe. In the year ended December 31, 2016, organizational redesign costs across all segments included $8.6 million for termination costs as a result of eliminated positions. Organizational redesign costs in the year ended December 31, 2016 included $4.4 million of costs related to the shutdown of facilities in APPT, $5.1 million of costs related to relocating our facilities in Belgium, Italy and Germany to the Czech Republic in APPT and MDCS and $0.5 million of costs related to the restructuring of Fluids in Europe. In the year ended December 31, 2016, organizational redesign costs across all segments included $13.3 million for termination costs as a result of eliminated positions.. (c) Long term equity options in Corporate included the non cash charges associated with stock based compensation awards granted to certain executives and independent directors in the three months and year ended December 31, 2017 and (d) Debt costs incurred during the year ended December 31, 2017 included $1.9 million of fees related to the 2017 Term Loan Facility. (e) Professionalfeesin thethree monthsendeddecember31, 2017 and 2016 included $1.6 million and $2.2 million of costsforstrategicorganizational initiatives, respectively. Professional fees in the year ended December 31, 2017 and 2016 included $6.5 million and $4.7 million of costs for strategic organizational initiatives, respectively. (f) Non cash fair market value adjustments relate to acquisition accounting for the fair market value of inventory as part of our acquisition of CanGen in the fourth quarter of (g) Other costs in APPT for the three months and year ended December 31, 2017 primarily include $7.7 million of costs to write down the inventory of a discontinued product line and $1.4 million of goodwill impairment. Other costs for APPT in the year ended December 31, 2016 includes $1.4 million related to the impairment of certain software licenses. Other costs for Fluids in the year ended December 31, 2016 includes the write off of a $0.5 million non trade receivable. 18

19 ADJ. DILUTED EPS & FREE CASH FLOW RECONCILIATIONS Reconciliation of Adjusted Diluted Earnings Per Share: Reconciliation of Free Cash Flow: 19